Multimel N7-1000 E (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin)

The blend supplies the body’s fundamental building blocks for protein synthesis, restores nitrogen balance, and supports cellular metabolism. Delivered directly into the bloodstream, the amino acids become immediately available for tissue repair, immune function, and energy production, especially when oral intake is impossible.

The prescribed dose of Multimel N7-1000 E is determined by the treating clinician based on the patient’s weight, clinical condition, renal and hepatic function, and overall nutritional goals. Healthcare professionals calculate the infusion rate to meet individual amino‑acid requirements.

Use of Multimel N7-1000 E in pregnancy or while breastfeeding should only occur when clearly indicated and after a risk‑benefit assessment by the prescriber. Limited data are available, so it is generally reserved for situations where the mother cannot meet nutritional needs by other means.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

Multimel N7-1000 E offers a balanced mixture of ten essential and non‑essential amino acids in a single intravenous formulation, matching the profile of many standard TPN solutions. Compared with products that contain additional electrolytes or vitamins, Multimel focuses solely on amino‑acid provision, allowing clinicians to tailor other components separately.

The product must be stored at 2‑8 °C, protected from light, and kept in its original sealed container. Do not freeze or shake the solution. Before administration, inspect for particulate matter or discoloration and allow the solution to reach room temperature if required by the infusion protocol.

Multimel N7-1000 E is administered intravenously, typically via a central venous catheter as part of a total parenteral nutrition regimen. The infusion rate is set by the healthcare team according to the patient’s calculated amino‑acid needs and monitored throughout the therapy.

Serious risks include anaphylactic reactions, hyperammonemia (especially in patients with liver dysfunction), and metabolic acidosis. Prompt recognition of these events and immediate medical intervention are essential. Regular laboratory monitoring helps mitigate these risks.

Patients with known hypersensitivity to any of the amino‑acid components, severe hepatic failure with uncontrolled ammonia levels, or those for whom a balanced oral/enteral nutrition plan is feasible should generally avoid this product. Clinical judgment is required for each individual case.